PPLPHARMA vs TATAINVEST: Stock Comparison

Head-to-head financial and trading comparison between Piramal Pharma Limited (PPLPHARMA) and Tata Investment Corporation Limited (TATAINVEST) in the Cross-Sector Peers sector.

PPLPHARMA

NSE: PPLPHARMA
Piramal Pharma Limited
₹196.88
1Y Return: +32.32%
52W High: ₹226.62
52W Low: ₹148.79
Annual Volatility: 32.84%
Check PPLPHARMA Trade Fees →

TATAINVEST

NSE: TATAINVEST
Tata Investment Corporation Limited
₹599.25
1Y Return: -15.97%
52W High: ₹732.50
52W Low: ₹599.25
Annual Volatility: 44.75%
Check TATAINVEST Trade Fees →

Key Metrics Comparison Table

MetricPPLPHARMATATAINVESTEdge / Winner
Current Market Price (CMP) ₹196.88 ₹599.25 —
1-Year Price Return +32.32% -15.97% PPLPHARMA (48.29% higher)
52-Week High ₹226.62 ₹732.50 —
52-Week Low ₹148.79 ₹599.25 —
30-Day Annualized Volatility 32.84% 44.75% PPLPHARMA (Steadier)
30-Day Average Daily Volume 3,775,308 1,709,411 PPLPHARMA (Higher Liquidity)
Statutory Cost to Trade ₹1 Lakh ₹118.50 ₹118.50 Identical statutory tariff

Frequently Asked Questions

Between PPLPHARMA and TATAINVEST, which stock gave better returns over the last year?

PPLPHARMA has outperformed TATAINVEST over the past 12 months with a gain of 32.32% compared to -15.97%.

Which stock is less volatile: PPLPHARMA or TATAINVEST?

PPLPHARMA demonstrated lower price volatility (32.84% annualized) compared to TATAINVEST (44.75%). Lower volatility generally indicates steadier price action during market downturns.

What is the statutory cost to buy ₹1,00,000 of PPLPHARMA vs TATAINVEST?

Statutory exchange and government charges (STT, NSE turnover fees, SEBI fee, Stamp duty, and GST) are identical for delivery purchases of equal rupee value across both stocks, totaling approximately ₹118.50 on discount brokers offering zero delivery brokerage (like Zerodha or Dhan).

Are PPLPHARMA and TATAINVEST direct sector competitors?

Yes, both companies operate within the Cross-Sector Peers sector in India and are actively tracked as sector peers by institutional and retail market participants.